Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    12356647 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed 75 or 150 mg Clopidogrel Maintenance Doses Following PCI (ISAR-CHOICE-2)
Condition: Coronary Disease
Intervention: Drug: Clopidogrel

Indicates status has not been verified in more than two years